A Clinical Trial to Evaluate the Effects of Mood Munchies Gummies on Mood, Emotional Balance, and Focus in Children
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07947251. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a single-arm, open-label, fully decentralized (virtual) clinical trial evaluating the effects of JoySpring Mood Munchies gummies on mood, emotional balance, and focus in children aged 4-8 years over 4 weeks of daily use. Forty children will take 1 gummy daily for 28 days, with parents or legal guardians serving as proxy reporters for all study assessments completed via the Citruslabs study platform. Parents/guardians will complete validated questionnaires at Baseline and at Weeks 1, 2, 3, and 4. The primary endpoint is the change from Baseline to Week 4 in the Strengths and Difficulties Questionnaire (SDQ) Emotional Symptoms subscale score. Secondary endpoints include changes in parent-reported child focus and attention, overall parent/guardian satisfaction and product perception, and the incidence, nature, and severity of adverse events throughout the study period.
Study identification
- NCT ID
- NCT07947251
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 40 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 4 Years to 8 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 24, 2026 (Actual)
- Primary completion
- Aug 20, 2026 (Actual)
- Completion
- Aug 20, 2026 (Actual)
- Last update posted
- Nov 18, 2026
2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Citruslabs | Las Vegas | Nevada | 89101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07947251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2026 · Synced Nov 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.